MYC and neoplasm: When challenged against primary mammary tumors, transgenic Omomyc dramatically reduced tumor expansion by reducing cell proliferation and enhancing apoptosis, in line with what had been shown in the MMTV-Wnt1 mouse model of breast cancer (81), and with previous reports showing that indirect inhibition of MYC is extremely effective in the treatment of TNBC models (82).